INDIANAPOLIS--(BUSINESS WIRE)--Anthem Inc. (NYSE:ANTM) has earned high Medicare Star Quality Ratings from the Centers for Medicare & Medicaid Services (CMS) for its Medicare Advantage (MA) plans for 2017. In the most recent ratings released by CMS, nearly 51 percent of Anthem Medicare Advantage members will be enrolled in plans that achieved four stars or higher (with five stars being the highest ranking) as compared with approximately 22 percent of members enrolled in plans that achieved four stars or higher in 2016.
“Anthem has a long-standing history of serving Medicare beneficiaries and, as a result, we understand the high expectations that Medicare Advantage customers have in terms of quality and service,” said Joseph R. Swedish, Chairman, President and CEO, Anthem. “Our company has made it one of our highest priorities to continuously improve the quality of the Medicare Advantage plans we offer through advances such as an expanded service area and product portfolio. This not only means that our current members are receiving better service, but that our company is positioned for significant growth in this business segment in the future. We are pleased that CMS has recognized our efforts in their 2017 Medicare Star Quality Ratings. As we move forward, we will continue to focus on enhancing the quality of our programs for our current members and those we hope to serve in the future.”
Over the last few years, Anthem has invested considerably in its Medicare programs, broadening its product portfolio, expanding its services area, increasing its local health plan staffing and deepening its level of provider and member engagement. As a result of all of these efforts, Anthem is anticipating much more meaningful growth in 2017 than in many years. These improved Star ratings reflect our continued investment in strengthening Anthem’s Medicare program.
CMS’ Medicare Star Rating system ranks the performance and quality of Medicare Advantage and Medicare prescription drug plans to help beneficiaries and their families compare plans. Star Ratings are calculated each year using a scale of one to five stars (with five being the best), and may change from year to year, depending on how the plan performs.
Medicare Advantage plans are rated on their ability to help members stay healthy, assist members in managing chronic (long-term) conditions, ensuring positive member experiences with their health plan, achieving member satisfaction, and providing effective customer service. Medicare Advantage and Medicare Prescription Drug plans are also rated on how well they perform on drug plan customer service, member complaints, member experience with drug plan and drug safety. Annual Star Ratings are posed on www.medicare.gov.
About Anthem, Inc.
Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their members access to the care they need. With over 73 million people served by its affiliated companies, including nearly 40 million enrolled in its family of health plans, Anthem is one of the nation’s leading health benefits companies. For more information about Anthem’s family of companies, please visit www.antheminc.com/companies.
This document contains certain forward-looking information about us that is intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. These risks and uncertainties include: those discussed and identified in our public filings with the U.S. Securities and Exchange Commission, or SEC; increased government participation in, or regulation or taxation of health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, or Health Care Reform; trends in health care costs and utilization rates; our ability to secure sufficient premium rates including regulatory approval for and implementation of such rates; our participation in federal and state health insurance exchanges under Health Care Reform, which have experienced and continue to experience challenges due to implementation of initial and phased-in provisions of Health Care Reform, and which entail uncertainties associated with the mix and volume of business, particularly in our Individual and Small Group markets, that could negatively impact the adequacy of our premium rates and which may not be sufficiently offset by the risk apportionment provisions of Health Care Reform; the ultimate outcome of our pending acquisition of Cigna Corporation (“Cigna”) (the “Acquisition”), including our ability to achieve the synergies and value creation contemplated by the Acquisition within the expected time period, or at all, and the risk that unexpected costs will be incurred in connection therewith; the ultimate outcome and results of integrating our and Cigna’s operations and disruption from the Acquisition making it more difficult to maintain businesses and operational relationships; the possibility that the Acquisition does not close, including, but not limited to, due to the failure to satisfy the closing conditions, including the receipt of required regulatory approvals; the risks and uncertainties detailed by Cigna with respect to its business as described in its reports and documents filed with the SEC; our ability to contract with providers on cost-effective and competitive terms; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon and funding risks with respect to revenue received from participation therein; a downgrade in our financial strength ratings; increases in costs and other liabilities associated with increased litigation, government investigations, audits or reviews; medical malpractice or professional liability claims or other risks related to health care services provided by our subsidiaries; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; non-compliance by any party with the Express Scripts, Inc. pharmacy benefit management services agreement, which could result in financial penalties, our inability to meet customer demands, and sanctions imposed by governmental entities, including the Centers for Medicare and Medicaid Services; events that result in negative publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; state guaranty fund assessments for insolvent insurers; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member or employee sensitive or confidential information, including the impact and outcome of investigations, inquiries, claims and litigation related to the cyber-attack we reported in February 2015; changes in economic and market conditions, as well as regulations that may negatively affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding indebtedness; general risks associated with mergers, acquisitions and strategic alliances; various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations; future public health epidemics and catastrophes; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. We do not undertake to update or revise any forward-looking statements, except as required by applicable securities laws. Investors are also advised to carefully review and consider the various risks and other disclosures discussed in our SEC reports.